Apyx Medical (APYX) Non-Current Debt (2010 - 2026)

Apyx Medical has reported Non-Current Debt for 14 years, with the latest figure at $35.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 2.81% year-over-year to $35.1 million; the trailing twelve-month figure through Mar 2026 stood at $35.1 million (up 2.81% YoY), and the FY2025 full-year result was $34.8 million, up 2.82% from the prior year.
• Non-Current Debt for Q1 2026 stood at $35.1 million, up from $34.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $35.1 million in Q1 2026, with the low at $9.0 million in Q3 2023.
• Historically, Non-Current Debt has averaged $31.8 million across 4 years, with a median of $33.9 million in 2024.
• The largest YoY upside for Non-Current Debt was 275.77% in 2024 against a maximum downside of 2.13% in 2024.
• Apyx Medical's Non-Current Debt stood at $33.2 million in 2023, then increased by 2.13% to $33.9 million in 2024, then advanced by 2.82% to $34.8 million in 2025, then gained by 0.68% to $35.1 million in 2026.
• The last three Non-Current Debt figures came in at $35.1 million (Q1 2026), $34.8 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.